Publications by authors named "Cymon Kersch"

Article Synopsis
  • * Imaging genomics explores how genetic and molecular features relate to imaging data, potentially transforming brain tumor diagnosis and treatment.
  • * The article reviews imaging genomics methods, recommends analytic techniques, discusses their clinical relevance, and proposes future research directions in tumor habitat analysis.
View Article and Find Full Text PDF
Article Synopsis
  • MRI with gadolinium (Gd) is commonly used to monitor glioblastoma treatment but lacks specificity in revealing the tumor's immune environment; ferumoxytol (Fe), an iron nanoparticle, targets macrophages and microglia within glioblastomas.
  • In a study involving stereotactic biopsy samples and RNA microarray analysis, researchers examined how different MRI contrast agents (Gd versus Fe) correlated with immune pathways and gene expression patterns in glioblastoma patients.
  • Findings indicated that Fe-enhanced imaging provided a better understanding of immune processes, showing higher levels of immune-related gene sets and M2 polarized macrophages, highlighting its potential to inform treatment and tumor biology more effectively than standard Gd-based imaging.
View Article and Find Full Text PDF
Article Synopsis
  • Poor clinical outcomes in glioblastoma patients may result from issues within the tumor's immune environment; understanding this could lead to better patient assessment through imaging techniques.
  • The study involved patients with newly diagnosed glioblastoma who underwent MRI and tissue sampling to analyze gene expression and identify different immune signatures associated with specific MRI features.
  • Results showed that different MRI phenotypes correlate with varying immune responses, with enhancing lesions reflecting a stronger immune signature compared to non-enhancing areas, indicating that MRI can be a valuable tool for assessing glioblastoma's immune microenvironment.
View Article and Find Full Text PDF

Background: Intra-arterial administration of chemotherapy with or without osmotic blood-brain barrier disruption enhances delivery of therapeutic agents to brain tumors. The aim of this study is to evaluate the safety of these procedures.

Methods: Retrospectively collected data from a prospective database of consecutive patients with primary and metastatic brain tumors who received intra-arterial chemotherapy without osmotic blood-brain barrier disruption (IA) or intra-arterial chemotherapy with osmotic blood-brain barrier disruption (IA/OBBBD) at Oregon Health and Science University (OHSU) between December 1997 and November 2018 is reported.

View Article and Find Full Text PDF
Article Synopsis
  • The article discusses the challenges faced in imaging brain tumors due to the rise of immune-modulating therapies and the need for personalized treatment plans.
  • It highlights the limitations of existing imaging techniques like gadolinium contrast-enhanced MRI and FDG PET, and emphasizes the importance of understanding the tumor's interaction with the immune system.
  • The article aims to provide insights on imaging methods for detecting neuroinflammation in brain tumors and offers practical guidance on using iron nanoparticle imaging as a tool for diagnosing and monitoring these malignancies.
View Article and Find Full Text PDF

Intracarotid arterial hyperosmolar mannitol (ICAHM) blood-brain barrier disruption (BBBD) is effective and safe for delivery of therapeutics for central nervous system malignancies. ICAHM osmotically alters endothelial cells and tight junction integrity to achieve BBBD. However, occurrence of neuroinflammation following hemispheric BBBD by ICAHM remains unknown.

View Article and Find Full Text PDF

Overexpression of O-methylguanine DNA methyltransferase (MGMT) contributes to resistance to chemo-radiation therapy (CRT) in brain tumors. We previously demonstrated that non-ablative radiation improved delivery of anti-MGMT morpholino oligonucleotides (AMONs) to reduce MGMT levels in subcutaneous tumor xenografts. We evaluate this approach to enhance CRT efficacy in rat brain tumor xenograft models.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma is a highly aggressive brain cancer with varied characteristics, making it difficult to develop effective personalized treatments; addressing intratumoral heterogeneity is key to better tumor classification.
  • Researchers used transcriptional profiles from glioblastoma samples to enhance patient stratification by focusing on the cellular tumor structure for more accurate analysis.
  • The study demonstrates that analyzing pure cellular tumor tissue can improve biomarker effectiveness, aiding in diagnostics, prognostics, and treatment strategies for glioblastoma patients.
View Article and Find Full Text PDF

Background And Purpose: The radiologic features and patterns of primary central nervous system lymphoma (PCNSL) at initial presentation are well described. High response rates can be achieved with first-line high-dose methotrexate (HD-MTX) based regimens, yet many relapse within 2 years of diagnosis. We describe the pattern of relapse and review the potential mechanisms involved in relapse.

View Article and Find Full Text PDF

The mammalian brain is supplied with blood by specialized vasculature that is structurally and functionally distinct from that of the periphery. A defining feature of this vasculature is a physical blood-brain barrier (BBB). The BBB separates blood components from the brain microenvironment, regulating the entry and exit of ions, nutrients, macromolecules, and energy metabolites.

View Article and Find Full Text PDF

Background: We tested the hypothesis that αv-integrin and the human epidermal growth factor receptor type 2 (HER2) interact with each other in brain trophic metastatic breast cancer cells and influence their invasive phenotype.

Methods: Clones of MDA-MB231BR human breast cancer cells with stable knock down of αv-integrin in combination with high or low levels of HER2 were created. The interactions of these two proteins and their combined effect on cell migration and invasion were investigated in vitro and in vivo.

View Article and Find Full Text PDF

The evolution of the blood feeding adaptation in mosquitoes required hormonal coordination of multiple physiological processes (behavior, digestion, diuresis, oogenesis). The Aedes kinins (leucokinin-like neuropeptides) are involved in post blood feeding physiological processes, having diuretic and myotropic functions. To understand the in vivo contribution of the kinin receptor to overall female post-prandial fluid excretion, RNAi knockdown was followed by fluid secretion assays which proved its fundamental role in rapid diuresis.

View Article and Find Full Text PDF

Arthropod hormone receptors are potential targets for novel pesticides as they regulate many essential physiological and behavioral processes. The majority of them belong to the superfamily of G protein-coupled receptors (GPCRs). We have focused on characterizing arthropod kinin receptors from the tick and mosquito.

View Article and Find Full Text PDF

It is known that insect kinins increase diuresis and fluid secretion in the Aedes aegypti Malpighian tubule, causing a rapid drop of the transepithelial resistance and increasing chloride conductance from the hemolymph towards the tubule lumen. The tubule is composed of both principal and stellate cells. The main route for increased chloride influx upon kinin treatment is proposed to be paracellular, with septate junctions acquiring increased chloride selectivity and conductance.

View Article and Find Full Text PDF